Bentall Operation in a Patient with Severe Hemophilia A and Marfan Syndrome by Use of a Biologic Composite Graft

Simple item page
dc.contributor.authorYildirim F.
dc.contributor.authorOzbakkaloglu A.
dc.contributor.authorOzturk T.
dc.contributor.authorTetik O.
dc.date.accessioned2024-07-22T08:12:10Z
dc.date.available2024-07-22T08:12:10Z
dc.date.issued2016
dc.description.abstractWe describe a patient with severe hemophilia A and Marfan syndrome who underwent an elective Bentall operation. Because of the severe hemophilia, anticoagulation could not be given postoperatively; thus, a biologic Valsalva conduit graft was used. During the procedure, factor VIII was given as a bolus dose just before incision, then by continous infusion intraoperatively to maintain the factor VIII activity level between 200% and 300%. Minimal postoperative bleeding occurred. The infusion was continued postoperatively at a lower dose until all chest tubes, pacing wires, and invasive catheters were removed. The patient was discharged on postoperative day 7 without adverse events. © 2016 The Society of Thoracic Surgeons.
dc.identifier.DOI-ID10.1016/j.athoracsur.2015.09.011
dc.identifier.issn00034975
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15952
dc.language.isoEnglish
dc.publisherElsevier USA
dc.rightsAll Open Access; Bronze Open Access
dc.subjectAdult
dc.subjectAortography
dc.subjectBiological Products
dc.subjectBlood Vessel Prosthesis
dc.subjectCardiovascular Surgical Procedures
dc.subjectElective Surgical Procedures
dc.subjectFollow-Up Studies
dc.subjectHeart Valve Prosthesis
dc.subjectHemophilia A
dc.subjectHumans
dc.subjectMale
dc.subjectMarfan Syndrome
dc.subjectProsthesis Design
dc.subjectblood clotting factor 8 concentrate
dc.subjectbiological product
dc.subjectadult
dc.subjectanticoagulation
dc.subjectaorta valve regurgitation
dc.subjectaorta valve replacement
dc.subjectArticle
dc.subjectascending aorta surgery
dc.subjectbentall operation
dc.subjectcardiopulmonary bypass
dc.subjectcase report
dc.subjectcomposite graft
dc.subjectcomposite material
dc.subjectcomputed tomographic angiography
dc.subjectdisease severity
dc.subjectdrug dose increase
dc.subjectechocardiography
dc.subjectelective surgery
dc.subjectfunnel chest
dc.subjectheart surgery
dc.subjecthemophilia A
dc.subjecthuman
dc.subjectmale
dc.subjectMarfan syndrome
dc.subjectoutcome assessment
dc.subjectphysical examination
dc.subjectpostoperative hemorrhage
dc.subjectpostoperative period
dc.subjectpriority journal
dc.subjectsurgical drainage
dc.subjectsurgical technique
dc.subjecttreatment planning
dc.subjectaortography
dc.subjectblood vessel prosthesis
dc.subjectcardiovascular surgery
dc.subjectcomplication
dc.subjectfollow up
dc.subjectheart valve prosthesis
dc.subjecthemophilia A
dc.subjectMarfan syndrome
dc.subjectprocedures
dc.subjectprosthesis design
dc.titleBentall Operation in a Patient with Severe Hemophilia A and Marfan Syndrome by Use of a Biologic Composite Graft
dc.typeArticle

Files

Collections

Scopus Koleksiyonu